Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLK
3576
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $600K | ﹤0.01% |
44,648
+27,733
| +164% | +$456K |
|
|
ENV
3577
DELISTED
ENVESTNET, INC.
ENV
| $600K | ﹤0.01% |
12,200
-14,470
| -54% | -$775K |
|
3578
Galectin Therapeutics
GALT
$356M
| $599K | ﹤0.01% |
174,603
+168,393
| +2,712% | +$804K |
|
3579
CALL
Invesco
IVZ
$14.3B
| $599K | ﹤0.01% |
35,800
-38,100
| -52% | -$762K |
|
3580
Axcelis
ACLS
$4.42B
| $596K | ﹤0.01% |
33,479
-16,145
| -33% | -$287K |
|
3581
CALL
AGCO
AGCO
$6.96B
| $596K | ﹤0.01% |
10,700
+9,900
| +1,238% | +$559K |
|
3582
CALL
Cadence Design Systems
CDNS
$89.2B
| $596K | ﹤0.01% |
13,700
+1,500
| +12% | +$65.1K |
|
3583
Methode Electronics
MEI
$593M
| $596K | ﹤0.01% |
25,598
-21,216
| -45% | -$598K |
|
3584
SiriusPoint
SPNT
$2.7B
| $596K | ﹤0.01% |
61,740
-37,050
| -38% | -$398K |
|
3585
AXT Inc
AXTI
$5.07B
| $593K | ﹤0.01% |
136,322
+120,790
| +778% | +$671K |
|
3586
Emcor
EME
$36.7B
| $593K | ﹤0.01% |
9,936
-49,798
| -83% | -$3.45M |
|
|
ESGR
3587
DELISTED
Enstar Group
ESGR
| $593K | ﹤0.01% |
3,542
-67,294
| -95% | -$12.2M |
|
3588
Marten Transport
MRTN
$1.24B
| $593K | ﹤0.01% |
54,875
-29,532
| -35% | -$370K |
|
|
XLRN
3589
DELISTED
Acceleron Pharma
XLRN
| $593K | ﹤0.01% |
13,607
-13,576
| -50% | -$678K |
|
3590
CALL
Eastman Chemical
EMN
$8.43B
| $592K | ﹤0.01% |
8,100
+3,900
| +93% | +$311K |
|
3591
Pegasystems
PEGA
$5.51B
| $592K | ﹤0.01% |
24,734
+2,434
| +11% | +$63.8K |
|
|
CSOD
3592
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $591K | ﹤0.01% |
11,710
-33,248
| -74% | -$1.69M |
|
|
CADE
3593
DELISTED
Cadence Bank
CADE
| $590K | ﹤0.01% |
22,555
-172,852
| -88% | -$5.03M |
|
|
VSTO
3594
DELISTED
Vista Outdoor Inc.
VSTO
| $590K | ﹤0.01% |
51,958
-123,744
| -70% | -$1.62M |
|
3595
Ezcorp Inc
EZPW
$1.76B
| $589K | ﹤0.01% |
76,185
+3,606
| +5% | +$34.2K |
|
3596
Matsons
MATX
$6.39B
| $589K | ﹤0.01% |
18,399
-33,724
| -65% | -$1.25M |
|
3597
United Natural Foods
UNFI
$2.94B
| $588K | ﹤0.01% |
55,462
-48,355
| -47% | -$1.02M |
|
|
PR
3598
Permian Resources
PR
$17.7B
| $587K | ﹤0.01% |
53,324
+30,696
| +136% | +$527K |
|
|
WNS
3599
DELISTED
WNS Holdings
WNS
| $587K | ﹤0.01% |
14,210
+13,187
| +1,289% | +$630K |
|
|
APHA
3600
DELISTED
Aphria Inc. Common Shares
APHA
| $587K | ﹤0.01% |
+103,177
| New | +$813K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.